Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme
Creators
- 1. General Surgery, Wake Forest University School of Medicine, Winston-Salem, NC (United States)
- 2. Hypertension and Vascular Research Center, Wake Forest University School of Medicine, Winston-Salem, NC (United States)
- 3. Internal Medicine/Molecular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC (United States)
- 4. Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, NC (United States)
- 5. Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL (United States)
- 6. Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham VA Medical Center, Birmingham, AL (United States)
- 7. Internal Medicine/Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC (United States)
- 8. Internal Medicine/Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC (United States)
Description
We showed previously that rat angiotensin-(1-12) [Ang-(1-12)] is metabolized by chymase and angiotensin converting enzyme (ACE) to generate Angiotensin II (Ang II). Here, we investigated the affinity of cardiac chymase and ACE enzymes for Ang-(1-12) and Angiotensin I (Ang I) substrates. Native plasma membranes (PMs) isolated from heart and lung tissues of adult spontaneously hypertensive rats (SHR) were incubated with radiolabeled 125I-Ang-(1-12) or 125I-Ang I, in the absence or presence of a chymase or ACE inhibitor (chymostatin and lisinopril, respectively). Products were quantitated by HPLC connected to an in-line flow-through gamma detector. The rate of 125I-Ang II formation from 125I-Ang-(1-12) by chymase was significantly higher (heart: 7.0 ± 0.6 fmol/min/mg; lung: 33 ± 1.2 fmol/min/mg, P < 0.001) when compared to 125I-Ang I substrate (heart: 0.8 ± 0.1 fmol/min/mg; lung: 2.1 ± 0.1 fmol/min/mg). Substrate affinity of 125I-Ang-(1-12) for rat cardiac chymase was also confirmed using excess unlabeled Ang-(1-12) or Ang I (0–250 μM). The rate of 125I-Ang II formation was significantly lower using unlabeled Ang-(1-12) compared to unlabeled Ang I substrate. Kinetic data showed that rat chymase has a lower Km (64 ± 6.3 μM vs 142 ± 17 μM), higher Vmax (13.2 ± 1.3 μM/min/mg vs 1.9 ± 0.2 μM/min/mg) and more than 15-fold higher catalytic efficiency (ratio of Vmax/Km) for Ang-(1-12) compared to Ang I substrate, respectively. We also investigated ACE mediated hydrolysis of 125I-Ang-(1-12) and 125I-Ang I in solubilized membrane fractions of the SHR heart and lung. Interestingly, no significant difference in 125I-Ang II formation by ACE was detected using either substrate, 125I-Ang-(1-12) or 125I-Ang I, both in the heart (1.8 ± 0.2 fmol/min/mg and 1.8 ± 0.3 fmol/min/mg, respectively) and in the lungs (239 ± 25 fmol/min/mg and 248 ± 34 fmol/min/mg, respectively). Compared to chymase, ACE-mediated Ang-(1-12) metabolism in the heart was several fold lower. Overall our findings suggest that Ang-(1-12), not Ang I, is the better substrate for Ang II formation by chymase in adult rats. In addition, this confirms our previous observation that chymase (rather than ACE) is the main hydrolyzing enzyme responsible for Ang II generation from Ang-(1-12) in the adult rat heart.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2016.07.100Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2016.07.100;
- PII
- S0006-291X(16)31222-0;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 478
- Journal Issue
- 2
- Journal Page Range
- p. 559-564
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 49046264
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ADULTS; ANGIOTENSIN; ENZYMES; HEART; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; LUNGS; RATS; SUBSTRATES
- Descriptors DEC
- AGE GROUPS; ANIMALS; BODY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR SYSTEM; CHROMATOGRAPHY; DRUGS; GLOBULINS; LIQUID COLUMN CHROMATOGRAPHY; MAMMALS; ORGANIC COMPOUNDS; ORGANS; PROTEINS; RESPIRATORY SYSTEM; RODENTS; SEPARATION PROCESSES; VASOCONSTRICTORS; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.